Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
17322 | 541 | 36.4 | 72% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CYCLOPENTENONE PROSTAGLANDINS | Author keyword | 14 | 50% | 4% | 20 |
2 | DELTA12 PROSTAGLANDIN J2 | Author keyword | 6 | 80% | 1% | 4 |
3 | DELTA 12 PROSTAGLANDIN J2 | Author keyword | 6 | 100% | 1% | 4 |
4 | PROSTAGLANDIN J2 | Author keyword | 5 | 36% | 2% | 12 |
5 | AEDES ALBOPICTUS CELLS | Author keyword | 4 | 47% | 1% | 7 |
6 | CYCLOPENTENONE PROSTAGLANDIN | Author keyword | 4 | 47% | 1% | 7 |
7 | CYCLOPENTENONE | Author keyword | 4 | 19% | 4% | 19 |
8 | ELECTROPHILE RESPONSIVE PROTEOME | Author keyword | 3 | 100% | 1% | 3 |
9 | PROSTAGLANDIN A2 | Author keyword | 3 | 40% | 1% | 6 |
10 | DELTA12 PGJ2 | Author keyword | 2 | 44% | 1% | 4 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CYCLOPENTENONE PROSTAGLANDINS | 47 | 31% | 24% | 130 |
2 | DELTA 12 PROSTAGLANDIN J2 | 33 | 74% | 5% | 25 |
3 | ENDOGENOUS ELECTROPHILE | 26 | 80% | 3% | 16 |
4 | 9 DEOXY DELTA 9 DELTA 12E PROSTAGLANDIN D2 | 21 | 85% | 2% | 11 |
5 | DELTA12 PROSTAGLANDIN J2 | 15 | 77% | 2% | 10 |
6 | DELTA12 PGJ2 | 11 | 78% | 1% | 7 |
7 | POTENTIAL INDUCERS | 11 | 78% | 1% | 7 |
8 | ANTINEOPLASTIC PROSTAGLANDINS | 7 | 67% | 1% | 6 |
9 | SERIES PROSTAGLANDINS | 6 | 80% | 1% | 4 |
10 | PROTEIN THIOL MODIFICATION | 6 | 100% | 1% | 4 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
15-Deoxy-Delta(12,14)-prostaglandin J(2) as an electrophilic mediator | 2015 | 1 | 49 | 45% |
Cyclopentenone prostaglandins: New insights on biological activities and cellular targets | 2001 | 405 | 134 | 49% |
MODIFICATION OF CYSTEINE RESIDUES BY CYCLOPENTENONE PROSTAGLANDINS: INTERPLAY WITH REDOX REGULATION OF PROTEIN FUNCTION | 2014 | 6 | 128 | 41% |
PROSTAGLANDINS IN THE TREATMENT OF CANCER | 1994 | 48 | 55 | 84% |
Chemical implications for antitumor and antiviral prostaglandins: Reaction of Delta(7)-prostaglandin A(1) and prostaglandin A(1) methyl esters with thiols | 1997 | 85 | 70 | 63% |
Proteomic studies on protein modification by cyclopentenone prostaglandins: Expanding our view on electrophile actions | 2011 | 15 | 124 | 48% |
PROSTAGLANDIN-J2 - ANTITUMOR AND ANTIVIRAL ACTIVITIES AND THE MECHANISMS INVOLVED | 1990 | 136 | 103 | 54% |
Cyclopentenone: a special moiety for anticancer drug design | 2006 | 26 | 42 | 57% |
BIOLOGICAL-ACTIVITIES AND MECHANISMS OF ACTION OF PGJ2 AND RELATED-COMPOUNDS - AN UPDATE | 1992 | 167 | 105 | 44% |
Neuroinflammation and J2 prostaglandins: linking impairment of the ubiquitin-proteasome pathway and mitochondria to neurodegeneration | 2015 | 1 | 228 | 18% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CHARTERHOUSE THER EUT S | 2 | 67% | 0.4% | 2 |
2 | ESTRUCTURA FUNC PROT | 1 | 15% | 1.5% | 8 |
3 | MOL CHIRAL UNIT | 1 | 25% | 0.7% | 4 |
4 | CIENCIAS PROT | 1 | 50% | 0.2% | 1 |
5 | ESTRUCTURA FUNCION PROT | 1 | 50% | 0.2% | 1 |
6 | MINDCNS SIGNALING | 1 | 50% | 0.2% | 1 |
7 | CHEM CHIKUSA KU | 1 | 29% | 0.4% | 2 |
8 | CANC PROTEOM GRP | 0 | 33% | 0.2% | 1 |
9 | RECH CARDIOVASC METAB DIABETOL NUTR | 0 | 33% | 0.2% | 1 |
10 | UNIT FISIOL ANIM | 0 | 33% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000162678 | 15D PGJ2//15 DEOXY DELTA12 14 PROSTAGLANDIN J2//PPAR RESEARCH |
2 | 0.0000141702 | CRTH2//MOL BEHAV BIOL//PROSTAGLANDIN D 2 |
3 | 0.0000129529 | NITRO FATTY ACIDS//NITRATED FATTY ACIDS//NITRATED LIPIDS |
4 | 0.0000128216 | PPAR GAMMA//PPAR RESEARCH//TROGLITAZONE |
5 | 0.0000117274 | HEPOXILIN A3//CLAVULARIA VIRIDIS//HEPOXILINS |
6 | 0.0000086410 | TRICYCLODECADIENONE//INDANES HYDRINDANES//NIJMEGEN SON |
7 | 0.0000083627 | GLUCOSE AND GLUTAMINE//GLUCOSE AND GLUTAMINE METABOLISM//GLUTAMINE OXIDATION |
8 | 0.0000071256 | THROMBOCYTOSIS//TCIPA//TUMOR CELL INDUCED PLATELET AGGREGATION |
9 | 0.0000068876 | MED PHYSIOL UNIT//GAMMA LINOLENIC ACID//YORKSHIRE EXPT CANC MED |
10 | 0.0000067707 | SERV 151Z2//PP 2A//STRITCH MED OTOLARYNGOL |